Literature DB >> 26556566

Hypertension and lifetime risk of stroke.

Tanvir Chowdhury Turin1, Tomonori Okamura, Arfan Raheen Afzal, Nahid Rumana, Makoto Watanabe, Aya Higashiyama, Yoko Nakao, Michikazu Nakai, Misa Takegami, Kunihiro Nishimura, Yoshihiro Kokubo, Akira Okayama, Yoshihiro Miyamoto.   

Abstract

BACKGROUND: The lifetime risk (LTR) articulates the probability of disease in the residual lifetime for an index age. These estimates can be useful for general audience-targeted knowledge translation activities against hypertension. There are only a few reports on lifetime of impact of hypertension on stroke events in Asians in whom stroke incidence is higher than Westerners.
METHODS: The Suita Study, a cohort study of cardiovascular diseases in Japan, was established in 1989. We included all participants who were stroke free at baseline. Age (in years) was used as the time scale. Age-specific incidence rates were calculated with person-year method within 10-year bands. We estimated the sex and index-age specific LTR of first-ever stroke with taking the competing risk of death into account.
RESULTS: We followed 5783 men and women during 1989-2007 for 74 933 person-years. During the follow-up period, 276 (149 men and 127 women) participants had incident stroke. Of them, majority were cerebral infarction; 166 (102 men and 64 women). The LTR of stroke, accounted for competing risk of death, at 45 years of age for men without hypertension was 17.21% and it was 32.79% for hypertensive men. Among the hypertensive patients, participants with stage 2 or greater hypertension had higher LTR of stroke than the participants with stage 1 hypertension. This increased LTR of stroke for hypertensive patients were also observed among women and across all index ages for stroke.
CONCLUSION: In this urban community-based population, we observed that hypertension has significant effect on the residual LTR of stroke among both men and women of middle age, specifically for ischemic stroke.

Entities:  

Mesh:

Year:  2016        PMID: 26556566     DOI: 10.1097/HJH.0000000000000753

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  25 in total

Review 1.  Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.

Authors:  Austin C Boese; Seong C Kim; Ke-Jie Yin; Jean-Pyo Lee; Milton H Hamblin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

2.  Signal of Carotid Intraplaque Hemorrhage on MR T1-Weighted Imaging: Association with Acute Cerebral Infarct.

Authors:  D Yang; Y Liu; Y Han; D Li; W Wang; R Li; C Yuan; X Zhao
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-09       Impact factor: 3.825

Review 3.  Impact of Conventional Stroke Risk Factors on Stroke in Women: An Update.

Authors:  Tracy E Madsen; Virginia J Howard; Monik Jiménez; Kathryn M Rexrode; Maria Czarina Acelajado; Dawn Kleindorfer; Seemant Chaturvedi
Journal:  Stroke       Date:  2018-02-08       Impact factor: 7.914

4.  Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study.

Authors:  Yukiko Imai; Takumi Hirata; Shigeyuki Saitoh; Toshiharu Ninomiya; Yoshihiro Miyamoto; Hirofumi Ohnishi; Yoshitaka Murakami; Hiroyasu Iso; Sachiko Tanaka; Katsuyuki Miura; Akiko Tamakoshi; Michiko Yamada; Masahiko Kiyama; Hirotsugu Ueshima; Shizukiyo Ishikawa; Tomonori Okamura
Journal:  Hypertens Res       Date:  2020-07-03       Impact factor: 3.872

5.  Sex Differences in Hypertension and Stroke Risk in the REGARDS Study: A Longitudinal Cohort Study.

Authors:  Tracy E Madsen; George Howard; Dawn O Kleindorfer; Karen L Furie; Suzanne Oparil; JoAnn E Manson; Simin Liu; Virginia J Howard
Journal:  Hypertension       Date:  2019-08-13       Impact factor: 10.190

Review 6.  Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach.

Authors:  Jiri Polivka; Jiri Polivka; Martin Pesta; Vladimir Rohan; Libuse Celedova; Smit Mahajani; Ondrej Topolcan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2019-02-20       Impact factor: 6.543

7.  Systematic Analysis of the Global, Regional and National Burden of Cardiovascular Diseases from 1990 to 2017.

Authors:  Zhenkun Wang; Aihua Du; Hong Liu; Ziwei Wang; Jifa Hu
Journal:  J Epidemiol Glob Health       Date:  2021-12-13

8.  Visit-to-visit Variability of Blood Pressure and Risk of Stroke: Results of the Kailuan Cohort Study.

Authors:  Haijiang Dai; Yao Lu; Lu Song; Xiaohong Tang; Ying Li; Ruifang Chen; Aijing Luo; Hong Yuan; Shouling Wu
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

9.  Blood pressure-lowering efficacy of indapamide SR/amlodipine combination in older patients with hypertension: A post hoc analysis of the NESTOR trial (Natrilix SR vs Enalapril in Hypertensive Type 2 Diabetics With Microalbuminuria).

Authors:  Olivier Hanon; Laure Caillard; Edouard Chaussade; Intza Hernandorena; Clemence Boully
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-18       Impact factor: 3.738

10.  Simultaneous Imaging of Cerebrovascular Structure and Function in Hypertensive Rats Using Synchrotron Radiation Angiography.

Authors:  Liping Wang; Zhihao Mu; Xiaojie Lin; Jieli Geng; Ti Qiao Xiao; Zhijun Zhang; Yongting Wang; Yongjing Guan; Guo-Yuan Yang
Journal:  Front Aging Neurosci       Date:  2017-11-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.